Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreatic Ductal Adenocarcinoma”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Looking for participantsNCT05851924
What this trial is testing

NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07153289
What this trial is testing

CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)

Who this might be right for
Carcinoma, Pancreatic DuctalPancreatic Neoplasms
University Hospital Tuebingen 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03806309
What this trial is testing

OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC

Who this might be right for
Pancreatic Ductal AdenocarcinomaLocally Advanced CancerMetastatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 106
Testing effectiveness (Phase 2)Looking for participantsNCT06831136
What this trial is testing

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The University of Texas Health Science Center, Houston 24
Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)UnknownNCT01676259
What this trial is testing

SiG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Silenseed Ltd 80
Testing effectiveness (Phase 2)Looking for participantsNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04821284
What this trial is testing

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+5 more
Flemming Forsberg 120
Testing effectiveness (Phase 2)Looking for participantsNCT07483983
What this trial is testing

Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

Who this might be right for
Metastatic/Locally Advanced Non-Small-Cell Lung CancerMetastatic/Locally Pancreatic Ductal Adenocarcinoma
Gustave Roussy, Cancer Campus, Grand Paris 60
Post-approval studies (Phase 4)WithdrawnNCT02570529
What this trial is testing

Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Yonsei University
Not applicableStudy completedNCT05888129
What this trial is testing

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Postoperative Complications
Asan Medical Center 1
Early research (Phase 1)Looking for participantsNCT06141031
What this trial is testing

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Washington University School of Medicine 18
Not applicableLooking for participantsNCT06984562
What this trial is testing

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA)
Fox Chase Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT07595172
What this trial is testing

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Locally Advanced and Metastatic Pancreatic Cancer
West China Hospital 55
Not applicableUnknownNCT04365049
What this trial is testing

Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
Sun Yat-sen University 100
Not applicableStudy completedNCT03257150
What this trial is testing

The Use of Irreversible Electroporation in Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Health Network, Toronto 12
Very early researchLooking for participantsNCT07089940
What this trial is testing

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+2 more
OHSU Knight Cancer Institute 12
Not applicableStudy completedNCT04310111
What this trial is testing

EUS-RFA for Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
First People's Hospital of Hangzhou 8
Large-scale testing (Phase 3)Study completedNCT00471146
What this trial is testing

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Who this might be right for
Carcinoma, Pancreatic Ductal
Pfizer 630
Load More Results